These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 15700047)
1. Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function. Hu F; Wang X; Pace TW; Wu H; Miller AH Mol Psychiatry; 2005 May; 10(5):426-8. PubMed ID: 15700047 [No Abstract] [Full Text] [Related]
2. [Pre-clinical and clinical profiles of celecoxib, a new specific cyclooxygenase-2 inhibitor]. Kimoto A; Hanaoka A; Sasamata M; Miyata K Nihon Yakurigaku Zasshi; 2008 Feb; 131(2):127-36. PubMed ID: 18277013 [No Abstract] [Full Text] [Related]
3. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells. Cui W; Yu CH; Hu KQ Clin Cancer Res; 2005 Nov; 11(22):8213-21. PubMed ID: 16299255 [TBL] [Abstract][Full Text] [Related]
4. Anti-implantation effects of indomethacin and celecoxib in rats. Sookvanichsilp N; Pulbutr P Contraception; 2002 May; 65(5):373-8. PubMed ID: 12057792 [TBL] [Abstract][Full Text] [Related]
5. Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells. Lim YJ; Rhee JC; Bae YM; Chun WJ World J Gastroenterol; 2007 Apr; 13(13):1947-52. PubMed ID: 17461495 [TBL] [Abstract][Full Text] [Related]
6. The potential role of cyclooxygenase-2 inhibitors in the treatment of experimentally-induced mammary tumour: does celecoxib enhance the anti-tumour activity of doxorubicin? Awara WM; El-Sisi AE; El-Sayad ME; Goda AE Pharmacol Res; 2004 Nov; 50(5):487-98. PubMed ID: 15458769 [TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib. Zhang GS; Liu DS; Dai CW; Li RJ Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520 [TBL] [Abstract][Full Text] [Related]
8. Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth. Bozzo F; Bassignana A; Lazzarato L; Boschi D; Gasco A; Bocca C; Miglietta A Chem Biol Interact; 2009 Dec; 182(2-3):183-90. PubMed ID: 19682443 [TBL] [Abstract][Full Text] [Related]
9. Celecoxib and cardiovascular risks. Brophy JM Expert Opin Drug Saf; 2005 Nov; 4(6):1005-15. PubMed ID: 16255660 [TBL] [Abstract][Full Text] [Related]
10. The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex). Wynn RL Gen Dent; 2000; 48(1):16-20. PubMed ID: 11199547 [No Abstract] [Full Text] [Related]
11. Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant melanoma cell lines. Bundscherer A; Hafner C; Maisch T; Becker B; Landthaler M; Vogt T Oncol Rep; 2008 Feb; 19(2):547-53. PubMed ID: 18202806 [TBL] [Abstract][Full Text] [Related]
12. Celecoxib: a novel treatment for lung cancer. Abou-Issa H; Alshafie G Expert Rev Anticancer Ther; 2004 Oct; 4(5):725-34. PubMed ID: 15485309 [TBL] [Abstract][Full Text] [Related]
13. Effects of cyclooxygenase inhibition on cardiovascular function in a hypercholesterolemic swine model of chronic ischemia. Chu LM; Robich MP; Bianchi C; Feng J; Liu Y; Xu SH; Burgess T; Sellke FW Am J Physiol Heart Circ Physiol; 2012 Jan; 302(2):H479-88. PubMed ID: 22037194 [TBL] [Abstract][Full Text] [Related]
14. Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression. Myint AM; Steinbusch HW; Goeghegan L; Luchtman D; Kim YK; Leonard BE Neuroimmunomodulation; 2007; 14(2):65-71. PubMed ID: 17713352 [TBL] [Abstract][Full Text] [Related]
15. The cyclooxygenase-2 inhibitor celecoxib is a potent inhibitor of human carbonic anhydrase II. Knudsen JF; Carlsson U; Hammarström P; Sokol GH; Cantilena LR Inflammation; 2004 Oct; 28(5):285-90. PubMed ID: 16134002 [TBL] [Abstract][Full Text] [Related]
16. Post-treatment, but not pre-treatment, with the selective cyclooxygenase-2 inhibitor celecoxib markedly enhances functional recovery from kainic acid-induced neurodegeneration. Gobbo OL; O'Mara SM Neuroscience; 2004; 125(2):317-27. PubMed ID: 15062975 [TBL] [Abstract][Full Text] [Related]
17. Are all COX-2 inhibitors created equal? Chang IJ; Harris RC Hypertension; 2005 Feb; 45(2):178-80. PubMed ID: 15623540 [No Abstract] [Full Text] [Related]
18. Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application. Ragel BT; Jensen RL; Gillespie DL; Prescott SM; Couldwell WT J Neurosurg; 2005 Sep; 103(3):508-17. PubMed ID: 16235684 [TBL] [Abstract][Full Text] [Related]
19. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455 [TBL] [Abstract][Full Text] [Related]
20. Effects of chronic celecoxib on testicular function in normal and lipopolysaccharide-treated rats. Winnall WR; Muir JA; Liew S; Hirst JJ; Meachem SJ; Hedger MP Int J Androl; 2009 Oct; 32(5):542-55. PubMed ID: 18522674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]